Filter
371
Filtered Results: 371
Text search:
Food
and
Drug
Administration
(FDA)
Featured
Recommendations
43
New Publications
133
Language
Document type
No document type
198
Guidelines
83
Studies & Reports
48
Manuals
16
Fact sheets
12
Strategic & Response Plan
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
13
Ghana
11
Myanmar / Burma
11
Philippines
9
USA
7
Russia
7
Colombia
6
Nigeria
6
Latin America and the Carribbean
5
Western and Central Europe
5
South Africa
5
Uganda
5
Nepal
4
Congo, Democratic Republic of
4
Ethiopia
4
South Sudan
4
Thailand
3
Kenya
3
Global
3
Germany
3
South–East Asia Region
3
Indonesia
3
Rwanda
2
Syria
2
Peru
2
Africa
2
Tanzania
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Argentina
2
Bangladesh
2
Brazil
2
Namibia
2
Sudan
2
Yemen
2
Angola
2
Sierra Leone
1
Chile
1
Singapore
1
Senegal
1
Malawi
1
Zimbabwe
1
Mozambique
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Eastern Europe
1
Botswana
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
35
COVID-19
28
Drugs & Medical Equipment
20
Policies & Guidelines HIV & TB
18
Policies
13
HIV & STI
13
TB
11
Hepatitis
10
Studies & Reports
8
Capacity Building
7
Reproductive Health
6
Pediatrics
5
Women & Child Health
5
Diabetes
4
Medical Devices & Equipment
4
Gynaecology & Obstetrics
4
Malaria
4
Pharmacy & Technologies
4
Vector Control
3
MPOX - Monkeypox
3
Virology
3
Community Health
3
Laboratory Quality Assurance
3
Medicines Donations
2
Clinical Training
2
Family Planning
2
Bacteriology
2
Cancer Treatment & Resources
2
Countries
2
Chagas
2
Communicable Diseases
2
Age & Elderly
2
Neonatal Care
2
Disease Prevention & Control
2
Communicable Diseases
1
Dental & Eye Care
1
Paediatrics
1
Pharmacy & Technology
1
Under-5 nutrition
1
Buruli Ulcer
1
Disaster Preparedness
1
Cancer
1
Cervical Cancer
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Vaccine-preventable Diseases
1
Pharmaceutical Assessments
1
Cardiovascular Diseases
1
Hemorrhagic Fever
1
Diarrhoeal Disease/Cholera
1
Clinical Guidelines
1
Information, Education and Communication (IEC)
1
Humanitarian Crisis
1
Statistics
1
Diarrhoea
1
General Guidelines
1
NTDs & Others
1
Maternal Health
1
Neurology & Psychology
1
Parasitology
1
Non-communicable Diseases
1
Key Resources
1
Toolboxes
Country specific documents
18
Children/Adolescents Mental Disorders
17
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
15
Drug resistant TB
11
Clinical Guidelines
10
Diagnostics & Laboratory Guidance
10
PPE Personel Protective Equipment
8
Studies
7
HIV testing & services
6
Clinical Aspects, Treatment & Prevention
6
Adults
6
Detection & Diagnosis
6
Antiretroviral Treatment ART
6
Country specific
5
Infection Control General
5
Essential Medicines
5
Substance Use Disorders & Addiction
5
Testing Guidelines
5
Treatment & Prevention
4
Children & Adolescents
4
Research
4
For Health Worker
4
Pharmacy Practice
4
Rational use of Medicine
4
Pharmacovigilance
4
others
4
Alzheimer's Disease & Dementia
4
Bipolar Affective Disorders
4
TB & Prisoners
4
Depression
4
Hepatitis
3
General
3
Essential Medicines & Medical Devices
3
Hospital Readiness/Essential Health Services
3
Communication Material
3
Biontech/Pfizer Comirnaty
3
Prices and Patents
3
Quality Assurance
3
Mental Disorders
3
Antimicrobial Resistance (AMR)
3
MPOX - Monkeypox
3
Overview, Studies & Reports
3
Neurological Disorders
3
Research & Access
3
Assessment
3
Preparedness & Prevention
3
ART Drug Resistance
2
Prevention & Control
2
Clinical Guidelines
2
Treatment Guidelines HIV
2
Public Health
2
TB & Other Vulnerable Populations
2
Drug resistance
2
International
2
Treatment Guidelines
2
Supporting tools
2
Oxygen Therapy
2
Blood Supply
2
TB/HIV
2
Preparedness, Response & Risk Communication
2
Logistics & Supply
2
Fair Allocation & Ethical Aspects
2
SARS-CoV-2 Variants
2
Vaccine Hesitancy & Myths
2
Falsified & Substandard
2
Medicine Donations
2
Supply Chain & Store Management
2
Reports & Studies
2
Chagas
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Women
2
Clinical Guidelines
2
Technical Information
2
Training
2
Technical Information
2
Roadmaps, Action Plans & Policies
2
TB/HIV Coinfection
2
Tobacco
2
Anxiety Disorders
2
Lobby and Advocacy
2
Plague Prevention & Control
2
Treatment Guidelines
1
Policies & Strategies
1
Clinical Guidelines
1
Male Circumcision
1
General Reports
1
TB & Drug Abuse
1
Agriculture & Veterinary
1
Posttraumatic stress disorder Adults
1
Faith-based Organizations
1
Surveillance
1
Background PTSD in children
1
Chemical Attacks
1
Preparedness, Response & Risk Communication
1
Opportunistic Infections
1
Policies & Programmes
1
Plague
1
Schizophrenia
1
Context, Facts & Travel Advice
1
Infection Control
1
Opoids
1
Curricula & Core Competencies
1
Drug resistance
1
General Studies & Reports
1
TB
1
Prophylaxis
1
Preparedness, Response & Risk Communication
1
Children
1
Training Supporting Material mhGAP
1
Clinical aspects
1
Attention deficit hyperactivity disorder (ADHD)
1
Laboratory & Sampling
1
Climate & Health
1
Laboratory
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Research & Development
1
Livestock production
1
Surveillance & Contact tracing
1
Faith-based Organizations
1
Clinical Guidelines
1
Scientific & Research Studies
1
Educational Settings
1
Workplace
1
Paediatrics
1
Physical Distancing
1
Medical & Community Masks
1
Access & Strategy
1
Gambling
1
Genomic sequencing
1
COVAX Initiative
1
Moderna
1
Johnson & Johnson
1
Research & Pipeline
1
Hygiene
1
Food environments
1
Overview & reports
1
Essential Medicines & Devices Lists
1
Pharmacy Management
1
Pharmaceutical Assessments
1
Resuscitation
1
One Health
1
Agriculture incl. animal husbandry
1
Waste Managment
1
Environment
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MOPX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Information & Education Material (IEC)
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Awareness
1
Global Overview
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Co-Morbidities (except TB)
1
Ghana
1
General
1
General Aspects
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
Asia
1
Diarrhoea
1
Prevention of mother-to-child transmission (PMTCT)
1
Germany
1
Situation Reports & Updates
1
Technical Information
1
Vision Loss & Blindness
1
Situation Reports
1
Zika Prevention & Control
1
Clinical Guidelines
1
Others
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Preparedness & Prevention
1
IEC Material Neurological Disorders
1
Eastern Europe & Central Asia
1
Laboratory & Diagnostics
1
AMR
1
Reports & Studies
1
Global Health Ethics
1
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arlington, VA: JSI Research & Training Institute, Inc....
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
FEY ENFOMASYON POU MOUN K’AP RESEVWA AVEK MOUN K’AP BAY SWEN OTORIZASYON POU ITILIZASYON IJANS (EUA) POU VAKSIN MODERNA COVID-19 POU ANPECHE CORONAVIRUSDISEASE 2019
(COVID-19) NAN PERSONN 18 ANE AK PI GRAN
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
Three Years After Enactment of the Drug Quality and Security Act
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
